Literature DB >> 2433702

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia.

R L Momparler, G E Rivard, M Gyger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2433702     DOI： 10.1016/0163-7258(85)90052-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  29 in total

Review 1.  Promising approaches in acute leukemia.

Authors:  J Cortes; H M Kantarjian
Journal:  Invest New Drugs       Date:  2000-02       Impact factor: 3.850

Review 2.  Epigenetic therapy of leukemia: An update.

Authors:  Nitin Jain; Adriana Rossi; Guillermo Garcia-Manero
Journal:  Int J Biochem Cell Biol       Date:  2008-10-17       Impact factor: 5.085

Review 3.  DNA methylation: its role in cancer development and therapy.

Authors:  Carla Kurkjian; Shivaani Kummar; Anthony J Murgo
Journal:  Curr Probl Cancer       Date:  2008 Sep-Oct       Impact factor: 3.187

Review 4.  Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome.

Authors:  Takayuki Ishikawa
Journal:  Int J Clin Oncol       Date:  2013-12-20       Impact factor: 3.402

5.  Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.

Authors:  Amber Ilyas; Zehra Hashim; Shamshad Zarina
Journal:  Mol Cell Biochem       Date:  2015-04-09       Impact factor: 3.396

6.  Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells.

Authors:  A R Karpf; P W Peterson; J T Rawlins; B K Dalley; Q Yang; H Albertsen; D A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

7.  Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.

Authors:  D Samid; S Shack; C E Myers
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes.

Authors:  Jacqueline S Garcia; Nitin Jain; Lucy A Godley
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

9.  Transbuccal delivery of 5-aza-2 -deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation.

Authors:  Ravichandran Mahalingam; Harish Ravivarapu; Sanjeev Redkar; Xiaoling Li; Bhaskara R Jasti
Journal:  AAPS PharmSciTech       Date:  2007-07-13       Impact factor: 3.246

10.  Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.

Authors:  Iskra Pusic; Jaebok Choi; Mark A Fiala; Feng Gao; Matthew Holt; Amanda F Cashen; Ravi Vij; Camille N Abboud; Keith E Stockerl-Goldstein; Meghan A Jacoby; Geoffrey L Uy; Peter Westervelt; John F DiPersio
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-05       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.